FDA just had a stupendous win in its battle against stem cell clinics
The FDA claimed these clinics were plying patients with an illegal drug derived from their stem cells. A federal court agrees.
Just as it began to seem that the battle against pseudoscience in medicine was being lost, a federal appeals court in San Francisco delivered a huge win for the Food and Drug Administration on its science-based regulation of stem cell clinics.
The three-member panel of the 9th Circuit Court of Appeals found that the FDA's definition of processed stem cells as a "drug" was correct. The judges also acc...
